Mucinous Breast Carcinoma: Clinicopathological Comparison With Invasive Ductal Carcinoma.

Autor:	Hashmi AA; Pathology, Liaquat National Hospital and Medical College, Karachi, PAK., Zia S; Pathology, Ziauddin University, Karachi, PAK., Yaqeen SR; Internal Medicine, Baqai Medical University, Karachi, PAK., Ahmed O; Internal Medicine, Liaquat National Hospital and Medical College, Karachi, PAK., Asghar IA; Pathology, Ascension St. John Hospital, Detroit, USA., Islam S; Internal Medicine, St. Vincent Health Center, Buffalo, USA.; Internal Medicine, Faisalabad Medical University, Faisalabad, PAK., Afzal A; Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, USA., Irfan M; Statistics, Liaquat National Hospital and Medical College, Karachi, PAK., Zia F; Pathology, Jinnah Sindh Medical University, Karachi, PAK., Ali J; Pathology, Liaquat National Hospital and Medical College, Karachi, PAK.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2021 Mar 02; Vol. 13 (3), pp. e13650. Date of Electronic Publication: 2021 Mar 02.
DOI:	10.7759/cureus.13650
Abstrakt:	Introduction Invasive ductal carcinoma (IDC) is the most common histological subtype of breast cancer. Conversely, many special types of breast carcinoma were described with varying prognosis and hormone receptor status. Mucinous carcinoma (MC) is a rare special subtype of breast cancer, and only a few studies have evaluated the clinicopathological and hormone receptor profile of this type of breast cancer. Therefore, in this study, we compared the clinicopathological characteristics of MC with IDC in our population. Methods A retrospective observational study was conducted in the Department of Histopathology, Liaquat National Hospital and Medical College, from January 2013 till December 2020, for eight years. During this period, 38 cases of MC were diagnosed and 1268 cases of IDC were identified. All specimens were grossed according to standard protocols and representative sections were submitted from tumors, resection margins, and lymph nodes. Slides were examined by histopathologists to determine tumor type and grade. Immunohistochemical (IHC) stains were applied to evaluate estrogen receptor (ER), progesterone receptor (PR), Ki67, and human epidermal growth factor receptor 2 (HER2/neu) statuses. Results The mean age of the patients with MC was 56.47±13.90 years, and most of the patients were above 50 years of age. The mean tumor size was 34.89±19.70 mm. Most tumors were grade 1 (68.4%) with a low mean Ki67 index (15.21±14.06%). Axillary metastasis was present in 31.6% of cases and all of them were nodal (N)-stage N1. ER, PR, and HER2/neu positivity were noted in 94.7%, 78.9, and 10.5% cases, respectively. Compared with IDC, a significant association of MC was noted with age, Ki67 index, tumor (T)-stage, N-stage, and tumor grade. MC cases had a higher mean age than IDC cases. Comparative analysis revealed that MC had a lower frequency of axillary metastasis, a lower mean Ki67 index, and a lower tumor grade than IDC. About biomarker status, MC was noted to have a higher frequency of ER and PR expression, and a lower frequency of HER2/neu expression than IDC. Conclusion MC is a rare subtype of breast cancer. However, it is important to recognize this subtype of breast cancer as it is associated with a prognostically better pathological profile, such as lower tumor grade and Ki67 index, lower frequency of axillary metastasis, higher expression of ER and PR, and lower expression of HER2/neu. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2021, Hashmi et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu